Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Conti

Showing results (281-290 of 346) with videos related to

Pageof 35
Sort By:
Scientific Reports|July 11, 2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumaticaRossana Scrivo, Valeria Silvestri, Francesco Ciciarello, et al.
Rheumatology (Oxford, England)|December 17, 2019
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohortMatteo Piga, Alberto Floris, Gian Domenico Sebastiani, et al.
Reumatismo|April 10, 2026
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseasesNicola Ughi, Roberto Padoan, Giovanni Adami, et al.
RMD Open|December 29, 2022
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational studyAlberto Floris, Elisabetta Chessa, Gian Domenico Sebastiani, et al.
Expert Opinion on Biological Therapy|May 14, 2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter studyMaria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.
Journal of Autoimmunity|June 1, 2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patientsTania Colasanti, Danilo Sabatinelli, Carmine Mancone, et al.
Rheumatology (Oxford, England)|November 15, 2011
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patientsMarcello Govoni, Stefano Bombardieri, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Pageof 35

Showing results (281-290 of 346) with videos related to

Sort By:
Pageof 35
Scientific Reports|July 11, 2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumaticaRossana Scrivo, Valeria Silvestri, Francesco Ciciarello, et al.
Rheumatology (Oxford, England)|December 17, 2019
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohortMatteo Piga, Alberto Floris, Gian Domenico Sebastiani, et al.
Reumatismo|April 10, 2026
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseasesNicola Ughi, Roberto Padoan, Giovanni Adami, et al.
RMD Open|December 29, 2022
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational studyAlberto Floris, Elisabetta Chessa, Gian Domenico Sebastiani, et al.
Expert Opinion on Biological Therapy|May 14, 2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter studyMaria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.
Journal of Autoimmunity|June 1, 2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patientsTania Colasanti, Danilo Sabatinelli, Carmine Mancone, et al.
Rheumatology (Oxford, England)|November 15, 2011
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patientsMarcello Govoni, Stefano Bombardieri, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Pageof 35